Page last updated: 2024-10-26

etodolac and Dermatitis Medicamentosa

etodolac has been researched along with Dermatitis Medicamentosa in 2 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, Y1
Takemoto, A1
Muto, M1
Ozkaya, E1
Keles, S1

Other Studies

2 other studies available for etodolac and Dermatitis Medicamentosa

ArticleYear
Acute generalized exanthematous pustulosis due to etodolac in a patient with an iliopsoas muscle abscess.
    Acta dermato-venereologica, 2011, Volume: 91, Issue:5

    Topics: Acute Disease; Aged; Biopsy; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etodolac; Exanthema; Human

2011
Etodolac-induced pigmenting fixed drug eruption.
    Clinical and experimental dermatology, 2007, Volume: 32, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Drug Interactions; Etodolac; Female; Humans

2007